Gabriella Miller Kids First Research Act 2.0

S 1624, the Gabriella Miller Kids First Research Act 2.0, redirects civil monetary penalties from securities violations to fund pediatric research. It transfers fines collected from companies violating food, drug, supplement, and cosmetic regulations (under the Securities Exchange Act) into a dedicated NIH pediatric research fund. The bill amends the Public Health Service Act to require the NIH Director to coordinate pediatric research using these funds and avoid duplication of existing efforts. It also mandates a 4-year report to Congress detailing funded projects and advancements in pediatric research. This policy change directly affects the NIH, pediatric research initiatives, and companies subject to the securities penalties.